Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

4 treatments under study, led by Brief Therapeutic Intervention

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Terminated1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06505239Not ApplicableCompletedPrimary

Assessing the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol Intoxication

NCT03059628Not ApplicableTerminatedPrimary

Evaluation of a Personalized Normative Feedback Repeatedly Delivered Via a Mobile Application After a Brief Therapeutic Intervention on Alcohol-related Risks:

Showing all 2 trials

Research Network

Common Treatments

  • Brief Therapeutic Intervention1
  • Evaluation Questionnaire1
  • Fsdf2r6acp1
  • Personalized Normative Feedback1

Active Sponsors

  • Quantum Biopharma1
  • Rennes University Hospital1

Top Investigators

Activity Timeline